High binding of CCR1 to RANTES enhanced the recruitment of inflammatory cells at the site of endometriosis and correlated significantly and positively with the severity of dysmenorrhea, providing a potential biomarker for the pain and inflammatory response associated with deep-infiltrating endometriosis (DIE) [135]. This evidence concerns the gene CCR1 and endometriosis.